This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring both a bromophenyl and cyclobutyl group, makes it a valuable intermediate in the creation of molecules targeting central nervous system (CNS) disorders. Researchers explore its potential in designing compounds that interact with specific receptors or enzymes in the brain, which could lead to treatments for conditions like depression, anxiety, or neurodegenerative diseases. Additionally, it may serve as a building block in medicinal chemistry for optimizing drug properties such as potency, selectivity, and bioavailability. Its hydrochloride form ensures stability and solubility, facilitating its use in various experimental and formulation processes.